News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • UBS says extreme concentration in two Korean semiconductor names drove roughly $70B of foreign equity outflows in H1 2026, pressuring the won.
  • Lawmakers warn Bill Pulte's appointment as acting DNI could derail renewal of Section 702 FISA ahead of its Friday expiry unless reversed.
  • White House officials have drafted a plan to buy the Chagos Islands and assume control of Diego Garcia from Mauritius.
  • United CEO Scott Kirby says a full merger with American is unlikely after American's rebuff, but United may buy slots, gates or other assets.
  • Embraer expects to introduce E2 regional jets in China over time, positioning E190/E195 between the C909 and C919.
  • Skeena is about 49% through Eskay Creek construction with $750M of senior secured notes closed, and current weakness creates a buy opportunity.

Latest Articles

ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026

ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026

Enlivex Ltd., a Nasdaq-listed quality longevity company, announced its Gold Sponsorship of the Proof of Talk 2026 summit in Paris, featuring a presentation on its unique combination of clinical-stage longevity therapeutics development and a prediction markets treasury strategy anchored in the Rain protocol. This innovative approach targets aging-re…

UroGen Announces Agreement Resolving Patent Litigation Relating to JELMYTO® (mitomycin) for pyelocalyceal solution

UroGen Announces Agreement Resolving Patent Litigation Relating to JELMYTO® (mitomycin) for pyelocalyceal solution

UroGen Pharma Ltd. announced a settlement with Teva Pharmaceuticals resolving patent litigation concerning Teva's generic version of JELMYTO® (mitomycin) for pyelocalyceal solution. The agreement grants Teva a non-exclusive license to market the generic after September 15, 2030, preserving nearly all of UroGen's patent exclusivity. The resolution a…

Comscore’s Q1 2026 AI Intelligence Report Shows Scale of Claude’s Breakout Growth as AI Continues to Influence Search, Discovery and Consumer Decisions

Comscore’s Q1 2026 AI Intelligence Report Shows Scale of Claude’s Breakout Growth as AI Continues to Influence Search, Discovery and Consumer Decisions

Comscore's Q1 2026 AI Intelligence Report reveals significant growth in AI assistant platforms, particularly Anthropic's Claude, which saw an 1,858% rise in desktop conversations. ChatGPT remains the leader with 55% year-over-year growth in desktop conversations. The report highlights the increasing integration of AI into search and consumer decisi…

SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing

SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing

SpyGlass Pharma has appointed Mike Pinder as Vice President of Marketing to lead commercial efforts for its late-stage BIM-IOL System, currently in Phase 3 trials for glaucoma and cataract treatment. Pinder brings extensive ophthalmology commercial launch experience, positioning the company for potential successful commercialization upon FDA approv…

Polar Power Highlights Sharply Improved First Quarter 2026 Performance and Recent Operational Progress

Polar Power Highlights Sharply Improved First Quarter 2026 Performance and Recent Operational Progress

Polar Power, Inc. released its Q1 2026 financial results showing a major improvement in gross margin to 65.7%, a narrowed net loss by 86%, and reduced operating expenses by 22% compared to Q1 2025. The company also secured a lower rent agreement, improved stockholders' equity, and expanded its sales backlog largely driven by international telecom c…

Plug Power Strengthens Liquidity Through $44 Million Federal ITC Transfer for St. Gabriel Hydrogen Facility

Plug Power Strengthens Liquidity Through $44 Million Federal ITC Transfer for St. Gabriel Hydrogen Facility

Plug Power announced the successful sale of a $39.2 million federal investment tax credit related to its St. Gabriel, Louisiana hydrogen liquefaction plant. This transaction enhances Plug Power's liquidity and supports its strategic financial management and expansion of its hydrogen infrastructure in the United States. The St. Gabriel facility, one…

ProKidney Appoints Kenneth Locke as Chief Technical Officer

ProKidney Appoints Kenneth Locke as Chief Technical Officer

ProKidney Corp., a Nasdaq-listed late clinical-stage cell therapy company focused on chronic kidney disease, appoints Kenneth Locke as Chief Technical Officer to lead technical operations as it advances its Phase 3 REGEN-006 trial and prepares for potential commercialization of its autologous cell therapy, rilparencel.

Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report

Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report

Alignment Healthcare released its 2025 Impact Report showcasing its effective care model that leads to healthier members by providing earlier, coordinated care. The company demonstrated substantial reductions in emergency room visits, inpatient admissions, skilled nursing facility admissions, and 30-day hospital readmission rates compared to Medica…

INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial

INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial

INmune Bio Inc. announced statistically significant treatment effects of its drug candidate XPro1595 on white matter MRI biomarkers in the Phase 2 MINDFuL trial for early Alzheimer's disease. The treatment demonstrated broad target engagement, particularly in patients with elevated inflammation biomarkers, supporting the company's precision-medicin…

BIO-key Delivers Phishing-Resistant Biometric Security to Alabama’s AOD Federal Credit UnionBynum, AL

BIO-key Delivers Phishing-Resistant Biometric Security to Alabama’s AOD Federal Credit UnionBynum, AL

BIO-key International has announced a strategic partnership with BlueAlly to deliver its PortalGuard biometric identity and access management solution to AOD Federal Credit Union. The deployment enhances security by replacing traditional MFA methods with phishing-resistant biometric authentication, improving user experience and reducing operational…

CoreWeave rises on BNP Paribas upgrade and Nvidia-driven AI momentum

CoreWeave rises on BNP Paribas upgrade and Nvidia-driven AI momentum

CoreWeave Inc. shares climbed in premarket trading after BNP Paribas began coverage with an outperform rating and a $192 price target. The move followed a sharp one-day gain tied to a broader rally in Nvidia shares after CEO Jensen Huang’s keynote at Computex and GTC Taipei 2026, and came with analyst commentary highlighting CoreWeave’s strategic r…

Verizon announces extension of early participation date and early results of its private exchange offers and consent solicitations for 11 series of notes open to certain investors

Verizon announces extension of early participation date and early results of its private exchange offers and consent solicitations for 11 series of notes open to certain investors

Verizon Communications has extended the early participation deadline for its private exchange offers and consent solicitations for 11 series of notes until June 16, 2026. The company also disclosed early participation results as of June 1, 2026, showing varying levels of tendered notes across different subsidiaries. These exchange offers aim to rep…

Netanyahu Criticized at Home After U.S. Intervention Halts Planned Strikes on Beirut

Netanyahu Criticized at Home After U.S. Intervention Halts Planned Strikes on Beirut

U.S. President Donald Trump announced that Israel would stop planned strikes on Hezbollah positions in southern Beirut after an agreement between Israel and the group to suspend mutual attacks. The move has drawn sharp criticism of Prime Minister Benjamin Netanyahu from political rivals who say he ceded control of Israeli security policy, even as e…

Israel Continues Strikes in Southern Lebanon After Withholding Raid on Beirut

Israel Continues Strikes in Southern Lebanon After Withholding Raid on Beirut

Israel maintained air and artillery strikes across southern Lebanon even after U.S. President Donald Trump urged Prime Minister Benjamin Netanyahu not to launch a major assault on Beirut’s southern suburbs. Lebanon’s government said Israel would refrain from attacking the Hezbollah-controlled Dahiyeh area and that Hezbollah would suspend attacks, b…

ZenaTech Completes its 23rd Drone as a Service Acquisition Expanding Colorado Presence in Southeast Denver Growth Corridor

ZenaTech Completes its 23rd Drone as a Service Acquisition Expanding Colorado Presence in Southeast Denver Growth Corridor

ZenaTech, Inc., a US-based technology company specializing in AI-powered drone solutions and Drone as a Service (DaaS), announced the completion of its 23rd acquisition with the purchase of High Prairie Survey Company in Colorado. This acquisition strengthens ZenaTech's presence in the rapidly growing southeastern Denver area and expands its recurr…